ArticleAIDS and behavior2026
Prevalence of Depression, Suicidality, Alcohol Use Disorder and Associated Factors Among Adults on Antiretroviral Therapy in Namibia.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increased risk associated with HIV infection and suicidality, depression, and alcohol use disorder underscores the need to treat mental illness in people living with HIV by integrating mental health services into routine HIV care. This study, conducted at nine health facilities providing antiretroviral treatment in Namibia from August and September 2022, aimed to determine the prevalence and factors associated with depression, suicidality, and alcohol use disorder among adults living with HIV/AIDS in Namibia. Amongst the 400 participants, the prevalence of depression, suicidality, and alcohol use disorder was 8%, 21%, and 24%, respectively. The prevalence of depression and suicidality was highest in females (9.7%) and (24.7%), respectively, while males had a prevalence of alcohol use disorder of 35.3%. Patients with depression showed an increased and significant risk of suicidality (aOR=8.280, 95% CI: 3.644-18.815, p=0.000). For alcohol use disorder, male patients (aOR= 2.995, 95% CI: 1.816-4.938, p=<0.000) were more likely to have alcohol use disorder. Male sex (aOR= 0.447, 95% CI: 0.240-0.832, p=<0.011), depression (aOR= 8.283, 95% CI: 3.644-18.828, p=<0.000), and alcohol abuse (aOR= 2.393, 95% CI: 1.337-4.285, p=0.003) had an increased and significant association with suicidality. Overall, the study's results show that alcohol use disorder and suicidality are more prevalent in PLHIV compared to depression, and gender is a significant risk factor. Screening PLHIV and early initiation of treatment or interventions for various mental health disorders are important to improve retention, viral suppression, and other outcomes of ART.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.